Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Rohit Lal"'
Autor:
Rohit Lal, Vinit Kumar Thakur
Publikováno v:
Journal of Indian Association of Pediatric Surgeons, Vol 29, Iss 5, Pp 557-559 (2024)
The occurrence of teratoma is 1 in 4,000 live births. Head-and-neck region teratoma (epignathus) is rare. These patients present with facial disfigurement, respiratory problems, and difficulty in feeding. It warrants early excision to avoid any morbi
Externí odkaz:
https://doaj.org/article/6404849cda8a4b4bb66eb8f0c0bc7467
Publikováno v:
Clinical Practice and Cases in Emergency Medicine, Vol 4, Iss 4 (2020)
Introduction: Giant urinary bladder calculus in an adult is an uncommon entity. The number of patients with giant bladder calculi has decreased over recent years owing to wider availability of healthcare and better diagnostic modalities. Case Report:
Externí odkaz:
https://doaj.org/article/35e8998bbcd94f8990168bc04bbe36a0
Publikováno v:
Chinese Journal of Lung Cancer, Vol 17, Iss 2, Pp 116-121 (2014)
Externí odkaz:
https://doaj.org/article/86969400a3a842afa02b914a26f779de
Publikováno v:
International Journal of Clinical Biochemistry and Research. 9:301-305
Breast cancer (BC) is the most frequent cancer in women globally and the main cause of cancer-related mortality. MTHFR C677T is a functional polymorphism in the genes encoding a one-carbon metabolism enzyme that affect folate metabolism and may be as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd726b4b7fab2577c5c9ff65871c389a
https://doi.org/10.18231/j.ijcbr.2022.059
https://doi.org/10.18231/j.ijcbr.2022.059
Autor:
Michelle Scurr, George Demetri, Stan B. Kaye, S. Gail Eckhardt, Andrew Stephens, Katie Brock, Richard Gedrich, Ramesh Boinpally, Srinivasu Poondru, Jon Chick, Martin O. Leach, Nandita M. Desouza, James Spicer, Rohit Lal, Jennifer L. Spratlin, Stephen J. Gwyther, Natalie J. Serkova, Suzanne George, D. Ross Camidge, Hendrik-Tobias Arkenau, Timothy A. Yap
PDF file - 41K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b799e849ebbe5a00814a032f34a1638
https://doi.org/10.1158/1078-0432.22449198
https://doi.org/10.1158/1078-0432.22449198
Autor:
Johann S. de Bono, Bernd Hentsch, Vera Strobel, Bernhard Hauns, Anna Mais, Muyibat Olaleye, Isabel Casamayor, Ann Parker, Rebecca Kristeleit, L. Rhoda Molife, David Olmos, Rohit Lal, Joo Ern Ang, André T. Brunetto
Supplementary figure 1. Plot of resminostat concentration versus degree of HDAC enzyme inhibition at 2 hour post-dose on day 1 for all dose levels using the Hill model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39630264a00477f0eaf1ad5fce361f3e
https://doi.org/10.1158/1078-0432.22449708
https://doi.org/10.1158/1078-0432.22449708
Autor:
Michelle Scurr, George Demetri, Stan B. Kaye, S. Gail Eckhardt, Andrew Stephens, Katie Brock, Richard Gedrich, Ramesh Boinpally, Srinivasu Poondru, Jon Chick, Martin O. Leach, Nandita M. Desouza, James Spicer, Rohit Lal, Jennifer L. Spratlin, Stephen J. Gwyther, Natalie J. Serkova, Suzanne George, D. Ross Camidge, Hendrik-Tobias Arkenau, Timothy A. Yap
PDF file - 86K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::595520b703fab59320f3f2d449b22409
https://doi.org/10.1158/1078-0432.22449195
https://doi.org/10.1158/1078-0432.22449195
Autor:
Michelle Scurr, George Demetri, Stan B. Kaye, S. Gail Eckhardt, Andrew Stephens, Katie Brock, Richard Gedrich, Ramesh Boinpally, Srinivasu Poondru, Jon Chick, Martin O. Leach, Nandita M. Desouza, James Spicer, Rohit Lal, Jennifer L. Spratlin, Stephen J. Gwyther, Natalie J. Serkova, Suzanne George, D. Ross Camidge, Hendrik-Tobias Arkenau, Timothy A. Yap
PDF file - 39K, Association of sVEGFR2 changes and steady state OSI-930 levels at the end of the first 21-day dosing cycle in the 500mg BID expansion cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d5f344fd13905f7c692557f8ce024a
https://doi.org/10.1158/1078-0432.22449204.v1
https://doi.org/10.1158/1078-0432.22449204.v1
Autor:
Michelle Scurr, George Demetri, Stan B. Kaye, S. Gail Eckhardt, Andrew Stephens, Katie Brock, Richard Gedrich, Ramesh Boinpally, Srinivasu Poondru, Jon Chick, Martin O. Leach, Nandita M. Desouza, James Spicer, Rohit Lal, Jennifer L. Spratlin, Stephen J. Gwyther, Natalie J. Serkova, Suzanne George, D. Ross Camidge, Hendrik-Tobias Arkenau, Timothy A. Yap
PDF file - 47K, Association of sVEGR2 changes at the end of the first dosing cycle and patient response in the 500mg BID expansion cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05219e69e5b585c5b84a5a91ca199a34
https://doi.org/10.1158/1078-0432.22449201.v1
https://doi.org/10.1158/1078-0432.22449201.v1
Autor:
Michelle Scurr, George Demetri, Stan B. Kaye, S. Gail Eckhardt, Andrew Stephens, Katie Brock, Richard Gedrich, Ramesh Boinpally, Srinivasu Poondru, Jon Chick, Martin O. Leach, Nandita M. Desouza, James Spicer, Rohit Lal, Jennifer L. Spratlin, Stephen J. Gwyther, Natalie J. Serkova, Suzanne George, D. Ross Camidge, Hendrik-Tobias Arkenau, Timothy A. Yap
Purpose: OSI-930 is a novel, potent, oral small-molecule receptor tyrosine kinase inhibitor, predominantly against VEGF receptors (VEGFR), c-Kit, and platelet-derived growth factor receptors. A phase I trial was undertaken to determine safety, maximu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c98a4c3811d944993686c53ba361a3
https://doi.org/10.1158/1078-0432.c.6521577
https://doi.org/10.1158/1078-0432.c.6521577